Kilburn & Strode

Congratulations to Susumu Kitagawa, Richard Robson and Omar M. Yaghi who were jointly awarded the 2025 Nobel Prize in Chemistry "for the development of metal–organic frameworks". In this article, Alice Bumstead and Jessica Smart take a look at: ▪️ What metal–organic frameworks are ▪️ How metal–organic frameworks might be used to tackle some of the most pressing environmental issues being faced today; and ▪️ Trends in patent filings for metal–organic frameworks. 🔗 Click the link below to read the full article. https://lnkd.in/enPT7c6k

From 31 December 2025, many EU trade marks (EUTMs) and UK “clone” registrations created after Brexit could become vulnerable to cancellation for non-use. In this article, Ruby Vinsome explains the importance of reviewing your portfolio ahead of this deadline to identify registrations that may no longer be defensible or enforceable, and explores the actions you can take to reduce risk. https://lnkd.in/erMtmKdf

Since its entry into force on 1 July 2019, the Supplementary Protection Certificate (SPC) manufacturing waiver has continued to shape the regulatory and commercial landscape for generics and biosimilars in the European Union (EU). Introduced via Regulation (EU) 2019/933, the waiver aims to improve competitiveness of EU-based generics and biosimilar manufacturers, while still respecting the incentive framework underpinning SPCs. In this article, Beth Ormrod and Nick Bassil explore the manufacturing waiver’s practical implementation and the contrasting conclusions reached in national courts in relation to the notification requirements. https://lnkd.in/eYCVRFQD

We are proud to once again be awarded a Band 1 ranking in the Intellectual Property: Patent & Trade Mark Attorneys category in the 2026 edition of Chambers and Partners. Congratulations to Gwilym Roberts for being recognised as an Eminent Practitioner. Further congratulations to Jennifer Harris for Band 1 recognition in Patent Prosecution, and to Iain Stewart for Band 1 recognition in the Trade Marks category. We would also like to extend our deep thanks to Chambers, our clients and contacts for their exceptional feedback. Read more: https://lnkd.in/gb8XyrZu

Carol Nyahasha will be attending the 2025 AIDV-IWLA International Conference on 17-19 October in Verona. We would love to connect if you are attending too, please get in touch directly with Carol on LinkedIn.

In high value chemical areas where competition is rife, establishing a strong priority claim and carefully crafting the subsequent priority claiming application can be crucial to protecting a commercial chemical product. This key takeaways article follows a recent webinar where our experts Jessica Smart, Andrea Coles and Kathryn Bradley shared practical tips on how to draft a patent application to protect a chemical product in Europe. Pre-empting potential issues in this way allows the best chance of a European patent being granted with broad coverage and being robust enough to enforce and survive post-grant challenges. https://lnkd.in/e4AS_-SM

In the world of sport, where celebrations become as iconic as the goal-scoring moments themselves, athletes are increasingly recognising that their signature gestures can form part of their wider commercial and personal brand strategy.   In this article, Asma Abbarová and Carol Nyahasha discuss the recent flurry of activity surrounding Chelsea footballer Cole Palmer and his trade mark applications. They explore both the opportunities and potential pitfalls surrounding celebrity brand protection, and consider the important lessons that can apply to all brand owners seeking protection. https://lnkd.in/eqjPenfr

National Courts in France, Austria and Sweden have now applied the CJEU's judgment in combined cases C-119/22 (Teva) and C-149/22 (MSD), with differing conclusions on whether a combination product was considered to "fall under the invention" of the basic patent. In this article, counsel Dayle Callaghan delves into the judgment and summarises the decisions from the national courts. https://lnkd.in/ek_RaYFR

In the second article of our series examining the use of in silico data to support the patentability of biotech inventions, we continue to explore the role of in silico data - this time addressing its relevance to novelty and inventive step at the EPO. https://lnkd.in/eBGP7m7i

There is still time to register for this webinar using the link below!